Contact Us
Drug Search Results
More Filters [+]

Buserelin

Alternative Names: buserelin, suprefact
Latest Update: 2024-12-02
Latest Update Note: Clinical Trial Update

Product Description

Buserelin is a synthetic analog of gonadotropin-releasing hormone (GnRH). Buserelin binds to and activates pituitary gonadotropin releasing hormone (GnRH) receptors. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Buserelin)

Mechanisms of Action: LHRH Analogue

Novel Mechanism: Yes

Modality: Large Molecule

Route of Administration: Subcutaneous,Nasal

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Argentina | Australia | Austria | Belgium | Brazil | Bulgaria | Canada | Chile | Colombia | Denmark | Dominican Republic | Germany | Greece | Hungary | Iceland | India | Ireland | Italy | Japan | Jordan | Korea | Malaysia | Malta | Netherlands | New Zealand | Norway | Pakistan | Peru | Poland | Portugal | Russia | Slovenia | South Africa | Spain | Sweden | Taiwan | Thailand | United Kingdom | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Buserelin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title

03/17/2021

News Article

 Worldwide Peptide Cancer Therapeutics Industry to 2026 - Featuring Novartis, Amgen and Pfizer Among Others

03/16/2021

News Article

 Global Peptide Cancer Therapeutics Market (2021 to 2026) - Drug Dosage, Price & Clinical Trials Insight

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions